Travere Therapeutics Inc 2025年季度报告

(Address of Principal Executive Offices) (888)969-7879 N/A Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yes☑No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrantwas required to submit such files).Yes☑No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☑ The number of shares of outstanding common stock, par value $0.0001 per share, of the Registrant as of April28, 2025 was88,804,818. TRAVERE THERAPEUTICS, INC. Form 10-QFor the Fiscal Quarter Ended March31, 2025 TABLE OF CONTENTS PageNo. PART I – FINANCIAL INFORMATIONItem 1.Financial StatementsConsolidated Balance Sheets as ofMarch31, 2025(Unaudited) and December 31, 20244Unaudited Consolidated Statements of Operations and ComprehensiveLossfor the threemonthsendedMarch31,2025 and20245Unaudited Consolidated Statements of Stockholders'Equity for the threemonthsendedMarch31, 2025and20246Unaudited Consolidated Statements of Cash Flows for thethreemonths endedMarch31, 2025and 20247Notes to Unaudited Consolidated Financial Statements8Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations25Item 3.Quantitative and Qualitative Disclosures About Market Risk34Item 4.Controls and Procedures35 Item 1.Legal Proceedings35Item 1A.Risk Factors35Item 2.Unregistered Sales of Equity Securities and Use of Proceeds64Item 3.Defaults Upon Senior Securities64Item 4.Mine Safety Disclosures64Item 5.Other Information64Item 6.Exhibits65 FORWARD-LOOKING STATEMENTS This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Wordssuch as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such wordsare intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-looking statements. Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only bebased on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks anduncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by theforward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, withoutlimitation, those specifically addressed under the headings “Risk Factors” and “Management’s Discussion and Analysis of FinancialCondition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December31, 2024, and in thisQuarterly Report on Form 10-Q. You are urged not to place undue reliance on these forward-looking statements, which speak only as ofthe date of this report. In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. Thesestatements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe suchinformation forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements shouldnot be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information.These statements are inherently uncertain and you are cautioned to not unduly rely upon these statements. We file reports with the Securities and Exchange Commission ("SEC"). The SEC maintains a website (www.sec.gov) that containsreports, proxy and information statements, and other information regardin